Alan A Musso
CIK 1295830 · Chief Financial Officer · last filed 2026-02-04
Alan A Musso is a Chief Financial Officer who has filed 47 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for FULC, was dated Feb 4, 2026. Across all open-market trades the lifetime net is −$1.5M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
47
-$1.45M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FULC | Chief Financial Officer | — | $3.45 | — | $0 | 5 | 2026-02-04 |
| RNTX | Director | — | $0.96 | — | $0 | 1 | 2025-07-23 |
| Rein Therapeutics, Inc. (ALRN) Delisted | Director | — | $2.11 | — | $0 | 3 | 2024-12-06 |
| BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | CFO and Treasurer | 26,548 | $0.07 | $2.0K | -$1.45M | 14 | 2018-07-05 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-04 | FULC | Grant (A) | — | $0 | EDGAR |
| 2025-07-23 | RNTX | Grant (A) | — | $0 | EDGAR |
| 2025-01-28 | FULC | Grant (A) | — | $0 | EDGAR |
| 2024-12-06 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-08-22 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-30 | FULC | Grant (A) | — | $0 | EDGAR |
| 2024-01-19 | FULC | Grant (A) | — | $0 | EDGAR |
| 2023-11-02 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-08-09 | FULC | Grant (A) | — | $0 | EDGAR |
| 2018-07-05 | BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Grant (A) | — | $0 | EDGAR |